Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Chow

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Statistics in Medicine|May 1, 1990
Outlier detection in bioavailability/bioequivalence studiesS C Chow, S K Tse
Toxicology and Applied Pharmacology|September 18, 2012
Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition propertiesC P Lawrence, S C Chow
Journal of Biopharmaceutical Statistics|May 1, 1997
Statistical comparison between dissolution profiles of drug productsS C Chow, F Y Ki
Journal of Biopharmaceutical Statistics|March 1, 1994
On statistical characteristics of quality of life assessmentS C Chow, F Y Ki
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Sample size determination for the two one-sided tests procedure in bioequivalenceJ P Liu, S C Chow
Statistics in Medicine|October 1, 1991
On the estimation of total variability in assay validationS C Chow, S K Tse
Journal of Biopharmaceutical Statistics|January 1, 1991
The estimation of parameters from bulked samplesS C Chow, E V Nordheim
Journal of Biopharmaceutical Statistics|March 1, 1996
Statistical issues in quality-of-life assessmentS C Chow, F Y Ki
Statistics in Medicine|October 18, 2000
Preface. Bioequilavence measuresS C Chow, J P Liu
Journal of Biopharmaceutical Statistics|January 1, 1992
On assessment of bioequivalence under a higher-order crossover designS C Chow, J P Liu
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Statistics in Medicine|May 1, 1990
Outlier detection in bioavailability/bioequivalence studiesS C Chow, S K Tse
Toxicology and Applied Pharmacology|September 18, 2012
Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition propertiesC P Lawrence, S C Chow
Journal of Biopharmaceutical Statistics|May 1, 1997
Statistical comparison between dissolution profiles of drug productsS C Chow, F Y Ki
Journal of Biopharmaceutical Statistics|March 1, 1994
On statistical characteristics of quality of life assessmentS C Chow, F Y Ki
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1992
Sample size determination for the two one-sided tests procedure in bioequivalenceJ P Liu, S C Chow
Statistics in Medicine|October 1, 1991
On the estimation of total variability in assay validationS C Chow, S K Tse
Journal of Biopharmaceutical Statistics|January 1, 1991
The estimation of parameters from bulked samplesS C Chow, E V Nordheim
Journal of Biopharmaceutical Statistics|March 1, 1996
Statistical issues in quality-of-life assessmentS C Chow, F Y Ki
Statistics in Medicine|October 18, 2000
Preface. Bioequilavence measuresS C Chow, J P Liu
Journal of Biopharmaceutical Statistics|January 1, 1992
On assessment of bioequivalence under a higher-order crossover designS C Chow, J P Liu
Pageof 12